Mode
Text Size
Log in / Sign up

Antibiotic exposure is associated with an increased risk of developing Irritable Bowel SyndromeAntibiotic use is linked to higher risk of irritable bowel syndrome

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the association between antibiotic use and increased Irritable Bowel Syndrome risk, especially after gastrointestinal infections.

The study investigated the relationship between antibiotic exposure and the development of Irritable Bowel Syndrome. By comparing patients who had documented antibiotic use against a control group without such exposure, the researchers sought to determine if a correlation existed between these factors and the onset of the condition.

The results indicated that antibiotic use was associated with an increased incidence of Irritable Bowel Syndrome. This association was notably observed in patients who received antibiotics specifically for gastrointestinal infections. However, the authors noted that the findings were complicated by high heterogeneity in the data related to gastrointestinal infections.

Due to the high heterogeneity, the authors suggest that the power of the results is reduced. Clinicians should note this association while remaining mindful of the limitations regarding data consistency. The findings suggest a potential link between antibiotic use and IBS, but the strength of this association may be limited by the variability in the underlying studies.

Irritable bowel syndrome, or IBS, is a common and often uncomfortable condition that affects the digestive system. People with IBS frequently experience symptoms like cramping, abdominal pain, bloating, and changes in bowel habits. Because these symptoms can significantly impact daily life, understanding what factors might contribute to the development of IBS is very important for patients seeking to manage their long-term health.

To better understand this link, researchers conducted a large-scale meta-analysis. This type of study combines data from many different sources to look for patterns. This specific analysis looked at data from over 422,000 people. The researchers compared the rates of IBS in people who had been exposed to antibiotics against a group of people who had not used antibiotics. This large sample size helps researchers see broader trends in how certain medications might relate to digestive health.

The results showed a link between antibiotic use and the development of IBS. Specifically, the study found that 26 percent of people who used antibiotics developed IBS, compared to 20 percent of those who did not use antibiotics. When the researchers looked specifically at people who took antibiotics to treat gastrointestinal infections, the link appeared even stronger. These findings suggest that the use of antibiotics, particularly for stomach or intestinal infections, is associated with a higher risk of developing IBS symptoms.

However, it is important to look at these results with a balanced perspective. The study noted a high level of heterogeneity, which means the data came from many different sources that were not all similar. This variation can make it harder to determine the exact strength or certainty of the results. Because of this, the findings should be viewed as a link rather than a direct cause. The study does not mean that every person who takes an antibiotic will develop a digestive condition.

For patients today, this means that while there is a documented link between antibiotics and IBS, it is not a guarantee of what will happen to an individual. Doctors still prescribe antibiotics when they are necessary to treat infections. This research provides more information for healthcare providers and patients to discuss how certain treatments might affect long-term digestive health. It highlights the importance of monitoring digestive health following the completion of antibiotic courses.

What this means for you:
Research shows a link between antibiotic use and a higher risk of irritable bowel syndrome, especially after infections.

Study Details

Study typeMeta analysis
Sample sizen = 422,350
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
INTRODUCTION: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction which negatively affects patients' quality of life. It has been hypothesized that changes in gut microbiota composition and function evoked by antibiotic use represent a trigger for IBS development. This systematic review and meta-analysis aimed to assess the incidence of IBS after antibiotic use. METHODS: Medline, Embase, and Scopus, along with relevant conference abstracts and citation tracking were searched up to June 15th, 2025. Studies that reported new diagnoses of IBS in patients with documented antibiotic exposure vs controls without antibiotic exposure were included. Data extraction and quality assessment were performed independently by 2 reviewers. Pooled incidence rates per 1,000 person-years, along with incidence rate ratios (IRRs) with 95% confidence intervals (CI) were pooled; heterogeneity was expressed as I2 . Metaregression analysis was performed to assess the impact of confounding covariates. RESULTS: Thirty-one studies comprising a total of 422,350 patients (244,632 antibiotic users and 177,718 nonusers) were included. The overall pooled incidence of IBS was 26% in antibiotic users compared with 20% in nonusers, resulting in an IRR of 1.3 (95% CI: 1.07-1.58; P = 0.008). In sensitivity analyses including only studies in which antibiotics were used for gastrointestinal infections, the risk of developing IBS was higher for antibiotic users (IRR: 1.71; 95% CI: 1.16-2.51; P = 0.007), with high heterogeneity ( I2 > 90%) among studies. Geographical area, criteria for IBS diagnosis and study quality were associated with estimated effects, explaining the observed heterogeneity. DISCUSSION: Antibiotic use is associated with increased risk of developing IBS, especially after gastrointestinal infections. However, the significant study heterogeneity reduces the power of our results, suggesting that further high-quality research is needed to clarify this relationship.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.